Suchergebnisse - "Caby, Fabienne"

PubPharm (36)

1

High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours : results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Palich, R. | Arias-Rodríguez, A. | Duracinsky, M. | +89

2

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von González-Cordón, A. | Assoumou, L. | Moyle, G. | +117

3

Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR) : substudies of reservoirs and ultrasensitive drug resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Lambert-Niclot, S. | Abdi, B. | Bellet, J. | +113

4

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk : A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waters, L. | Assoumou, L. | González-Cordón, A. | +121

5

Striking differences in weight gain after cART initiation depending on early or advanced presentation : results from the ANRS CO4 FHDH cohort

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Grabar, S. | Potard, V. | Piroth, L. | +20

6

A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR) : a randomised, open-label, multicentre, parallel, non-inferiority trial

enthalten in: The lancet. HIV | 2022

von Landman, R. | de Truchis, P. | Assoumou, L. | +120

CommentIn: Lancet HIV. 2022 Feb;9(2):e68-e69. - PMID 35120635

7

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von González-Cordón, A. | Assoumou, L. | Moyle, G. | +117

8

CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection : A Collaborative Analysis of 20 European Cohort Studies

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Caby, F. | Guiguet, M. | Weiss, L. | +73

9

Adult-onset Still's disease in a patient with human immunodeficiency virus infection : pathophysiological link?

enthalten in: Rheumatology (Oxford, England) | 2020

von Pichon, M. | Claire, L. | Genet, P. | +3

10

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk : 48 week effects on subclinical cardiovascular disease

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Gonzalez-Cordon, A. | Assoumou, L. | Camafort, M. | +113